MLYS: Mineralys Therapeutics, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 874.03
Enterprise Value ($M) 759.94
Book Value ($M) 191.26
Book Value / Share 2.95
Price / Book 4.57
NCAV ($M) 190.71
NCAV / Share 2.95
Price / NCAV 4.58

Profitability (mra)
Return on Invested Capital (ROIC) -0.93
Return on Assets (ROA) -0.51
Return on Equity (ROE) -0.54

Liquidity (mrq)
Quick Ratio 14.02
Current Ratio 14.02

Balance Sheet (mrq) ($M)
Current Assets 205.35
Assets 205.90
Liabilities 14.65
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -192.40
Net Income -177.81

Cash Flow Statement (mra) ($M)
Cash From Operations -166.31
Cash from Investing 114.96
Cash from Financing 116.14

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
03-17 13D/A Ra Capital Management, L.p. 9.90 27.04
03-17 13D/A Samsara BioCapital, L.P. 9.10 12.65
02-14 13G/A Adams Street Partners Llc 2.30 -50.93
11-13 13G/A Catalys Pacific Fund, LP 17.40 -5.73
11-13 13G/A HBM Healthcare Investments (Cayman) Ltd. 4.50 0.00
11-13 13G/A TCG Crossover GP II, LLC 5.00 -22.45

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-02-12 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2024-11-12 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q
2024-08-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q
2024-05-09 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-04-17 87,146 297,436 29.30
2025-04-16 120,554 411,395 29.30
2025-04-15 82,697 371,424 22.26
2025-04-14 155,334 688,162 22.57

(click for more detail)

Similar Companies
MGNX – MacroGenics, Inc. MGTX – MeiraGTx Holdings plc
MIST – Milestone Pharmaceuticals Inc. MNMD – Mind Medicine (MindMed) Inc.
MRNA – Moderna, Inc.


Financial data and stock pages provided by
Fintel.io